DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Nalfurafine is an investigational drug.
There have been 6 clinical trials for Nalfurafine. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Pruritus, Kidney Failure, Chronic, and Liver Diseases. The leading clinical trial sponsors are Toray Industries, Inc, SK Chemicals Co.,Ltd., and Acologix, Inc.
Recent Clinical Trials for Nalfurafine
|TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus||Toray Industries, Inc||Phase 1|
|Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis||Toray Industries, Inc||Phase 2|
|A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)||Acologix, Inc.||Phase 3|